Clinical Trials Logo

Clinical Trial Summary

Febrile seizures are considered a very common syndrome presented in the pediatric emergency room. Witnessing these seizures may can cause anxiety in parents and generate them psychological sequelae such as major depressive disorder in the short term, or sleep disorders in the long term. An appropriate care for parents must be put in place in the emergency department, with the objective of improving their knowledge of this pathology and its care, and thus to reduce their anxiety and prevent potential inappropriate or even deleterious behavior and maneuvers towards the child.


Clinical Trial Description

Febrile seizures occupy a large place in pediatric practice in the emergency room, their prevalence varies between 3 and 8% in children under 7 years old, hence the notion of a very common syndrome. When parents witness this event, they can experience it as terrifying, and which can alone cause anxiety and generate psychological sequelae. In the literature, it is described that a third of the parents present a major depressive disorder after the event and a third of the parents still describe sleep disorders after one year. After the arrival at the pediatric emergency room following the febrile seizure, the priority is given to the care of the child and parents are given succinct medical information. Due to parental anxiety, which may still be significant at this time, this information may not be understood. All of this can make the parent's level of knowledge about this pathology and its management low, potentially leading to future behaviors and maneuvers (such as shaking) that are inappropriate or even harmful to the child. A different course with appropriate care for parents must be put in place in the emergency department, with the objective of improving their knowledge of this pathology, its care and to reduce parent's anxiety. This is why the CONSULFE childcare consultation is proposed in this research. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05947006
Study type Interventional
Source University Hospital, Toulouse
Contact Alex BRIGAND
Phone 05 34 55 84 11
Email brigand.a@chu-toulouse.fr
Status Not yet recruiting
Phase N/A
Start date July 13, 2023
Completion date February 13, 2025

See also
  Status Clinical Trial Phase
Completed NCT03481764 - Anthropogenetic Variability in the Group of Individuals With Febrile Seizures
Not yet recruiting NCT05008458 - Value of Von Willebrand Factor and Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital
Completed NCT04368936 - Relationship Between Polymorphisms of TRPV1 and KCC2 Gene in Children With Febrile Seizures
Completed NCT01694524 - Nervous System Infections Among Patients With Febrile Seizure N/A
Recruiting NCT05215366 - Value of Copeptin Assay in Children With Febrile Seizures at Sohag University Hospital
Completed NCT03165981 - Fever After Simultaneous Versus Sequential Vaccination in Young Children Phase 4
Completed NCT04967066 - A Cross-Sectional Study of Serum Levels of Adipocytokines in Children With Febrile Seizures
Terminated NCT01370044 - Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures Phase 2/Phase 3